Purple BiotechPPBT
13F holders, Q2 2025 (June 30)2holders +1
1new positions
0sold out
$2.35avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding Purple Biotech Ltd. (PPBT) in their 13F filings, up 1 from Q1 2025. 1 opened new positions and 0 sold out. The largest holders were EverSource Wealth Advisors, LLC ($38) and North Star Investment Management Corp. ($35).
- Company
- Purple Biotech Ltd.
- CUSIP
- 74638P109
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $38 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 16 shares bought, net +16 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| EverSource Wealth Advisors, LLC | 0.00% | New | 16 | $38 |
| North Star Investment Management Corp. | 0.00% | No change | 15 | $35 |
"% of holder's portfolio" is PPBT's weight in each manager's 13F, not the share of Purple Biotech Ltd. the manager owns.